Targeted intra-operative radiotherapy

Targeted Intra-Operative Radiotherapy

File:The technique of targeted intraoperative radiotherapy for breast cancer.png

The technique of targeted intraoperative radiotherapy for breast cancer

Targeted intra-operative radiotherapy (TARGIT) is a form of radiotherapy that is administered during surgery for cancer treatment. This technique is primarily used in the treatment of breast cancer, where it offers the advantage of delivering radiation directly to the tumor bed immediately after the tumor is removed, minimizing exposure to surrounding healthy tissues.

Technique

The TARGIT procedure involves the use of a specialized device that delivers a single, high dose of radiation to the area where the tumor was located. This is typically done in the operating room immediately following the surgical removal of the tumor. The radiation is delivered using a small, spherical applicator that is placed in the tumor cavity. The applicator emits radiation in a targeted manner, focusing on the tissues at highest risk of harboring residual cancer cells.

Advantages

One of the main advantages of TARGIT is that it reduces the need for multiple sessions of external beam radiotherapy, which is the traditional method of delivering radiation therapy. This can significantly reduce the overall treatment time for patients, as well as decrease the burden on healthcare facilities. Additionally, by targeting the radiation more precisely, TARGIT minimizes the exposure of healthy tissues to radiation, potentially reducing side effects.

Applications

While TARGIT is most commonly used in the treatment of breast cancer, research is ongoing to explore its use in other types of cancer. The technique is particularly beneficial for patients who may have difficulty accessing traditional radiotherapy facilities or for those who prefer a shorter treatment regimen.

Limitations

Despite its advantages, TARGIT is not suitable for all patients. The decision to use this technique depends on various factors, including the size and location of the tumor, the patient's overall health, and the specific characteristics of the cancer. Additionally, long-term data on the outcomes of TARGIT compared to traditional radiotherapy are still being collected.

Related Pages

• Breast cancer
• Radiotherapy
• Surgery
• Cancer treatment